Catalysts for Fougera Pharmaceuticals Inc
9 tracked
Mar 3, 2026
approval
FLUTICASONE PROPIONATE โ FDA approval
Fougera Pharmaceuticals Inc
โ
Feb 24, 2026
approval
MUPIROCIN โ FDA approval
Fougera Pharmaceuticals Inc
โ
Feb 24, 2026
approval
MUPIROCIN โ FDA approval
Fougera Pharmaceuticals Inc
โ
Feb 24, 2026
approval
MUPIROCIN โ FDA approval
Fougera Pharmaceuticals Inc
โ
Jan 12, 2026
approval
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE (FLUTICASONE PROPIONATE) โ FDA approval
Fougera Pharmaceuticals Inc
โ
Dec 10, 2025
approval
MOMETASONE FUROATE โ FDA approval
Fougera Pharmaceuticals Inc
โ
Oct 31, 2015
approval
MOMETASONE FUROATE โ FDA approval
Fougera Pharmaceuticals Inc
โ
Nov 30, 2005
approval
MUPIROCIN โ FDA approval
Fougera Pharmaceuticals Inc
โ
Mar 28, 2005
approval
MOMETASONE FUROATE โ FDA approval
Fougera Pharmaceuticals Inc
โ